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Summary
Magnetic resonance (MR) techniques enable in vivo
measurement of the atrophy of the brainstem and cer-
ebellum in spinocerebellar ataxia type 1 (SCA1) and 2
(SCA2) patients, which is accompanied by a decrease
in the concentration of N-acetyl aspartate (NAA) or of
the NAA/creatine ratio in the pons and cerebellum.
Mean diffusivity (D) is emerging as an additional sen-
sitive and quantitative MR parameter to investigate
brain diseases. In order to explore differences between
the MR features of SCA1 and SCA2 and correlate the
MR and clinical findings in the two conditions, we
examined 16 SCA1 patients, 12 SCA2 patients and
20 healthy control subjects. The MR protocol included
T1-weighted 3D gradient echo sequences, single-voxel
proton spectroscopy of the right cerebellar hemisphere
(dentate and peridentate region) and of the pons with a
PRESS sequence and an external reference quantita-
tion method, and (in nine patients with SCA1 and nine
patients with SCA2) diffusion-weighted echo-planar
images with reconstruction of the D maps. The patients
were evaluated with the Inherited Ataxia Clinical
Rating Scale (IACRS). Compared with control subjects,
the SCA1 and SCA2 patients showed a decrease (P <
0.01) in the volume of the brainstem and cerebellum
and in the concentration of NAA in the pons and
cerebellar hemisphere, whereas D of the brainstem
and cerebellum was increased. No significant difference
was observed between the SCA1 and SCA2 patient
groups. No correlation between cerebellar volume
and dentate and peridentate NAA concentration was
found in SCA1 or SCA2 patients. The volume of the
brainstem, D of the brainstem and cerebellum and the
concentration of NAA in the pons were correlated (P <
0.05) with the IACRS score in SCA1 but not in SCA2.
This discrepancy is in line with the clinical observation
that the clinical deficit has a later onset and faster
progression in SCA1 and an earlier onset and slower
progression in SCA2, and suggests that neurode-
generation of the brainstem is a comparatively more
rapid process in SCA1. In conclusion, our study
indicates that SCA1 and SCA2 substantially exhibit
the same MR features. The correlation in SCA1
between clinical severity and quantitative volumetric,
diffusion MRI and proton MR spectroscopy findings in
the brainstem indicates that these measurements might
be employed for longitudinal studies and hopefully as
surrogate markers in future pharmacological trials
of this condition.
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Introduction
The spinocerebellar ataxias are a group of autosomal domin-
ant diseases predominantly due to expansion of a CAG tri-
plet encoding polyglutamines (Subramony and Filla, 2001).
Spinocerebellar ataxias type 1 (SCA1) and type 2 (SCA2) are
the most common types in Italy (Pareyson et al., 1999). In
patients with SCA1 or SCA2, MRI enables in vivo assessment
of the volume loss of the cerebellum and brainstem (Burk
et al., 1996; Schols et al., 1997; Klockgether et al., 1998b) and
proton magnetic resonance spectroscopy (1H-MRS) demon-
strates a decrease in N-acetyl aspartate (NAA) concentration
or in the NAA/creatine (Cr) ratio in the cerebellum and pons
(Davie et al., 1995; Mascalchi et al., 1998; Boesch et al.,
2001). Diffusion MRI is emerging as a sensitive, quantitative
and reproducible tool to evaluate brain damage in white and
grey matter diseases (Bozzali et al., 2001; Cercignani et al.,
2001; Schocke, 2002; Cercignani et al., 2003) and was
recently employed in the evaluation of patients with inherited
or sporadic progressive ataxias (Della Nave et al., 2004).
Prior studies comparing the MRI features in SCA1 and
SCA2 were limited to quantitative assessment of atrophy
(Burk et al., 1996; Klockgether et al., 1998b). Moreover,
the correlation between the MR and clinical findings in
patients with spinocerebellar ataxias has not been thoroughly
investigated until now.
We compared quantitative volume and diffusion MRI and
1H-MRS findings in two groups of patients with SCA1 or
SCA2 and correlated the MR findings with the patients’ scores
on the Inherited Ataxia Clinical Rating Scale (IACRS) (Filla
et al., 1990).
Methods
Patient and control populations
Between January 2002 to September 2003, 28 patients with auto-
somal dominant cerebellar ataxia were defined as SCA1 (n¼ 16; nine
women and seven men, mean age 44 6 9 years, range 2959) or
SCA2 (n ¼ 12; three women and nine men, mean age 52 6 11.8
years, range 33–68) based on the results of genetic tests (Pareyson
et al., 1999), and gave their informed consent to participation in the
study which was approved by the Ethical Committee of the Careggi
Hospital University of Florence. They belonged to 22 (11 SCA1 and
11 SCA2) unrelated Italian families. Ten (four men and six women,
mean age 44 6 8 years; range 29–71 years) healthy volunteers with-
out familiar or personal history of neurological diseases served as
controls for volumetric MRI and (n ¼ 6) quantitative single-voxel
1H-MRS.
Control data for diffusion MRI were obtained in another 20
healthy subjects (eight women and 12 men, mean age 456 11 years).
On the day of the MR examination, the same neurologist
performed an extensive clinical evaluation in each patient, with
determination of the duration of symptoms (disease duration)
based on interview or review of hospital records. After the neuro-
logical examination, the score on the Inherited Ataxias Clinical Rat-
ing Scale (IACRS) was calculated. In this scale a progressive score
with a maximum of 46 points corresponds to a greater neurological
deficit, including signs of cerebellar and corticospinal tract involve-
ment (Filla et al., 1990).
MRI examinations
All examinations were performed on a 1.5 T system (Gyroscan
ACS-NT; Philips Medical System, Best, The Netherlands) equipped
with 23 mT/m gradient capability using a standard quadrature head
coil, which enables MRI and 1H-MRS.
The MRI acquisition protocol included scout images, sagittal
3 mm thick T1-weighted [repetition time (TR) 400 ms, echo time
(TE) 14 ms, number of excitations (NEX) 2] spin echo images and
coronal 1 mm thick 3D T1-weighted (TR 25 ms, TE 4.6 ms, flip angle
30) turbo gradient echo images covering the entire posterior cranial
fossa (PCF). Diffusion-weighted MRI was obtained according to a
previously reported protocol (Della Nave et al., 2004) in 18 patients
(nine SCA1, mean age 45 6 9 years; nine SCA2, mean age 52 6 12
years) and in the 20 controls. Briefly, 18 contiguous diffusion-
weighted slices were acquired on axial planes parallel to the bicom-
missural line from the medulla to the vertex with a double-shot
echo-planar sequence [TR 1600 ms, TE 80 (102) ms, echo-planar
imaging factor 15] with peripheral pulse gating. The slice thickness
was 6 mm, the field of view 230 mm and the matrix 100  256.
Diffusion-sensitizing gradients were applied along the three ortho-
gonal axes using a b value of 0 and 1000 s/mm2. For each slice,
the manufacturer’s software reconstructed the maps of the mean
diffusivity (D) which is the diffusivity derived from three measure-
ments in orthogonal directions.
For quantitative 1H-MRS we employed an external phantom cali-
bration method. The volume of interest (voxel) was a cube of 1.5–2 
1.5–2  1.5–2 cm (4.5–8 ml) placed in the basis pontis and in the right
dentate nucleus and surrounding the deep cerebellar hemisphere
(Fig. 1). To avoid inclusion of CSF spaces within the volume of inter-
est, the smallest voxel size was employed in patients with overt
atrophy. After automatic shimming and gradient tuning, water sup-
pression was obtained with an adiabatic radio frequency (RF) pulse
centred around the water peak with a spectral width of 60 Hz, followed
by dephasing crusher gradients. The performance of water signal sup-
pression was optimized by fine tuning the flip angle of the water
suppression RF pulse slightly in excess of 90 to achieve a minimal
residual water signal. A point-resolved proton spectroscopy sequence
(PRESS) technique was used for acquisition of the proton spectrum
with TR 2000 ms, and 128 measurements were made. With 512 spec-
tral points, each spectrum acquisition time was 4.24 min. For deter-
mination of metabolite T2 relaxation time, the spectra were obtained
with four TEs (80, 136, 272 and 400 ms) in all patients and controls.
Soon after each examination, a spherical phantom (volume 2.5
litres) containing a 30 mM solution of sodium acetate loaded with
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4.7 g/litre of sodium chloride was placed within the coil. To prevent
regional signal variations due to magnetic field inhomogeneity and
eddy currents, a water-suppressed PRESS sequence with TR 2000
and TE 30 ms was obtained with the same geometrical coordinates
of each single voxel acquired in the same subject in the cerebellum
and pons.
Data analysis
Volumetric MRI
The same operator, who was blind to the genetic, clinical, diffusion
MRI and 1H-MRS data, determined the volumes of the cerebellum
and of the brainstem and of the posterior cranial fossa on a remote
console (Philips Easy Vision, release 4.3). After manual landmark-
defined presegmentation, the volumes of cerebellum and brainstem
were calculated with a visually supervised automatic procedure in
which seeds were dropped on a structure of interest and automatically
grown to include all the connected pixels until the whole structure
was outlined. The boundaries of the cerebellum and brainstem were
defined on coronal oblique 2 mm thick images reformatted in order to
be parallel to the floor of ventricle IV. The grey and white matter of
the cerebellar vermis and hemispheres were measured from the pos-
terior to the anterior images until the inferior or middle cerebellar
peduncles. In the more anterior images, only the cortical grey matter
was included in the volume of the cerebellum, whereas the white
matter was considered as a portion of the brainstem. Computation of
the volume of the vermis was not performed since its separation of
the vermis from the cerebellar hemispheres was easy in the anterior
portions, due to the sulcus between the vermis and the tonsils, but
almost impossible in the posterior portions, where no clear landmark
is present. The upper limit of the brainstem was defined by a line
perpendicular to the cerebral peduncles traced between the widest
portion of the third ventricle, medially, and the lateral surface of the
cerebral peduncles, laterally, inclusive of the colliculi (see supple-
mentary material, Fig. 1). The lower limit of the brainstem was
defined by a line coinciding with the foramen magnum. For the
purpose of normalizing the cerebellar and brainstem volumes to
the individual size, the volume of the posterior cranial fossa were
evaluated in 5 mm thick reformatted axial images.
To assess intra-operator variability, the measurements of the
volumes of the cerebellum and brainstem in one patient were
repeated on five different days; the coefficient of variation was
0.7% for the volume of the brainstem and 1.2% for the volume of
the cerebellum.
Diffusion MRI
The diffusion-weighted images were processed according to a pro-
cedure reported previously (Della Nave et al., 2004) by another
operator who was blind to the genetic and clinical data and to the
volumetric MRI and 1H-MRS findings. Regional D was evaluated
with round regions of interest in the pons (one, 10 mm in diameter),
peridentate white matter (four, 5 mm in diameter, two on the left and
two on the right side) and middle cerebellar peduncles (two, 5 mm in
diameter, one on each side) avoiding CSF contamination (see sup-
plementary material, Fig. 2). For determination of the D values of the
entire brainstem and cerebellum and of the cerebral hemispheres, the
operator performed a two-step procedure consisting of manual seg-
mentation of the skull to define the intracranial volume followed by
application of a threshold to separate brain parenchyma from CSF
spaces. In particular, D maps of each slice were first manually seg-
mented for the exclusion of scalp soft tissues and skull bone and the
definition of intracranial volume. A second manual segmentation was
then applied to separate the posterior cranial fossa from the supra-
tentorial intracranial spaces (see supplementary material, Fig. 3).
Mean intra-operator coefficient of variation for segmentation of
the skull was 2.7% and for determination of the posterior cranial
fossa spaces it was 0.5% in 10 measurements taken on different days
in the same patient. To exclude CSF spaces from the D map histo-
grams, a threshold value of 239 mm2/s was adopted, which would
enable exclusion of 97.5% of the CSF-containing pixels, assuming a
Gaussian distribution of the CSF D value (Chun et al., 2000; Della
Nave et al., 2004). Histograms of D were computed for the
A
B
Fig. 1 Sagittal T1-weighted spin echo image (A) and coronal T1-
weighted gradient echo image (B) showing the location of the
4.5 ml volume of interest in the basis pontis and deep right
cerebellum in a patient with SCA1. Note the loss of bulk of the
brainstem and cerebellum.
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cerebellum and brainstem and for the cerebral hemispheres using a
custom-made program (MRIcro 1.27; courtesy of C. Rorden). Since
the curve of brain D on the histogram was not symmetrical, we
measured the median, i.e. the 50th percentile, rather than the
mean value of the D histograms of the brainstem and cerebellum
and of the cerebral hemispheres (Della Nave et al., 2004). In addition,
for the brainstem and cerebellum histogram, the 25th percentile
was calculated, which is expected to be less modified by possible
contamination by CSF. Post-processing of the diffusion weighted
images required approximately 1 h for each study.
1H-MRS
Spectra were preliminarily processed with zero filling, exponential
multiplication, Fourier transformation and manual phase correction,
and the areas of the peaks at 2.07, 3.00 and 3.20 p.p.m. were assigned
to NAA, Cr and choline (Cho). The possible presence of a peak at
1.3 p.p.m. exhibiting the phase reversal at the TE 272 and 136 ms
typical of lactate was recorded.
Quantitative analysis was performed according to a previously
reported procedure (Mascalchi et al., 2002a) with AMARES, a
non-linear least squares fitting algorithm operating in the time
domain (FID signal) (Vanhamme et al., 1997), as implemented in
the MRUI package (van den Boogaart A et al., 1996). A frequency-
selective filter centred at 4.7 p.p.m. to reduce the residual of the water
signal and exponential multiplication to reduce noise were applied to
the FID signal before quantitative processing (Van den Boogaart
et al., 1994).
The area of the acetate peak, Sac, was used to calculate metabolite
concentrations, Cmet, from the measured metabolite peak area
according to the expression
Cmet ¼ CacðSmet=SmeÞNac=Nmet
where Cac ¼ 30 mM, Nac ¼ 3 and Nmet is the number of protons
contributing to the metabolite peak.
For each spectrum a correction was performed for different coil
loading, transmit and receive gain between the in vivo and the phan-
tom measurements and for the T2 effects measured as indicated
below. No correction for blood vessels and CSF spaces were
made. The concentrations were expressed as millimoles per litre.
The T2 relaxation times of NAA, Cr and Cho in the cerebellum
and pons were determined by fitting the two-parameter (amplitude
S0, decay constant 1/T2) mono-exponential
SðtÞSoeTE=T2
to the data using a linear least squares algorithm.
To assess intra-operator variability, the concentrations and T2
relaxation times in the cerebellar spectrum of one patient were deter-
mined on five different days. The coefficient of variation was below
5% for all the measurements.
Statistical analysis
We employed the non-parametric Mann–Whitney U test for pre-
liminary assessment of differences between patients (SCA1 and
SCA2) and controls and between the two patient groups for age,
disease duration and IACRS scores.
The same test was then employed for the differences between the
three groups in the volume of the PCF, the cerebellar and brainstem
volumes normalized to PCF, the regional and histogram D values,
and the concentration and T2 relaxation time of NAA, Cr and Cho in
the cerebellum and pons.
The Pearson correlation (r) was calculated to assess the correlation
between disease duration and IACRS scores on the one hand and the
brainstem and cerebellar volumes, D and NAA concentrations in the
groups of SCA1 and SCA2 patients, separately. In all instances
significance was set at P < 0.05.
Results
The ages of patients and controls were not significantly
different.
The disease duration was significantly (P < 0.01) shorter in
SCA1 (mean 7.4 6 4.8 years) than in SCA2 (mean 15.2 6
12.5 years) patients, whereas the IACRS scores of the SCA1
(mean 11.56 6.5) and SCA2 (mean 14.86 3.0) patients were
not significantly different. The disease duration and
the IACRS scores were correlated (P < 0.01) in SCA1
(r ¼ 0.69) but not in SCA2 (r ¼ 0.32).
Volumetric MRI
The results of the volumetric evaluation are summarized in
Table 1.
The volumes of the cerebellum and brainstem normalized
to PCF were significantly (P < 0.001) lower in SCA1 and
SCA2 patients than in controls. The volume of the cerebellum
was smaller in SCA2 than in SCA1 patients but the difference
was not statistically significant. The volume of the brainstem
in SCA1 and SCA2 patients was similar.
The volumes of the PCF, of the brainstem and the cerebel-
lum in our patients and controls are provided in Table 1 of the
supplementary material.
Diffusion MRI
Table 2 details the results of the region of interest and histo-
gram analysis of D in SCA1 and SCA2 patients and controls.
Table 1. Volumetric MRI of the brainstem and cerebellum
in patients with SCA1 and SCA2 and healthy subjects
SCA1 SCA2 Healthy
controls
Volume of
brainstem
normalized to
the PCF
0.11 6 0.02*** 0.11 6 0.03*** 0.15 6 0.01
Volume of the
cerebellum
normalized to
the PCF
0.49 6 0.06*** 0.41 6 0.07*** 0.60 6 0.03
PCF ¼ posterior cranial fossa.***P < 0.001; all statistically
significant P values refer to the difference between SCA1 or
SCA2 patients and controls. No statistically significant difference
was observed between SCA1 and SCA2 for any of the MRI
measurements.
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The D in the middle cerebellar peduncles and the medulla
was increased in the SCA1 and SCA2 patients compared with
controls (P < 0.01). The increase in the peridentate white
matter D was significant (P ¼ 0.001) in SCA1 and borderline
(P ¼ 0.05) in SCA2. The pontine D was increased in SCA1
and SCA2 but the differences compared with the controls was
statistically significant (P < 0.05) for SCA2 only. The 25th
and 50th percentiles of the brainstem and cerebellum D were
(P < 0.01) higher in both SCA1 and SCA2 compared with
controls (Fig. 2).
The median, i.e. 50th percentile, of the D of the supraten-
torial brain was not statistically different in SCA1, SCA2 and
controls.
No significant difference for any D measurement was
observed between SCA1 and SCA2 patients.
1H-MRS
A lactate peak was observed in the pons of one SCA1 patient
only.
Table 3 reports the concentrations and T2 relaxation times
of the metabolites in the cerebellum and pons for SCA1 and
SCA2 patients and controls. The concentrations of NAA in the
cerebellum and pons were significantly (P < 0.01) reduced in
SCA 1 and SCA2 patients compared with controls. No sig-
nificant differences were observed in the cerebellum and pons
for the concentrations of Cr and Cho and for the T2 of NAA,
Cr and Cho. No significant differences were present between
SCA1 and SCA2 patients concerning all the MRS variables.
MR: clinical correlations
The volume of the brainstem (r ¼ 0.74), the median of
brainstem and cerebellar D (r ¼ 0.70) and the NAA concen-
tration in the pons (r ¼ 0.63) were significantly (P < 0.05)
correlated to the IACRS score in SCA1, but not in SCA2
patients (Fig. 3).
The volume of the cerebellum was inversely correlated
with the duration (years) of disease duration in SCA1 (r ¼
0.73; P ¼ 0.003) and in SCA2 (r ¼ 0.70, P ¼ 0.01). The
median of brainstem and cerebellar D was correlated with
disease duration (r ¼ 0.84, P ¼ 0.004) in SCA1 only. No
other significant correlation was observed.
Discussion
Autosomal dominant cerebellar ataxias (ADCAs) are progres-
sive diseases with an incidence of 1–10/100 000 (Gudmunds-
son, 1969; van de Warrenburg et al., 2002). Since there is no
effective therapy, they lead to severe disability and death
(Harding and Deufel, 1993). Molecular genetics enables
subdivision of autosomal dominant cerebellar ataxias in
several types and genotype–phenotype correlation studies
(Subramony and Filla, 2001).
SCA1 is associated with a CAG repeat expansion in chro-
mosome 6p encoding a protein of unknown function called
ataxin 1, whereas in SCA2 the CAG triplet expansion is
located at chromosome 12q, encoding a protein of unknown
function called ataxin 2 (Subramony and Filla, 2001). Clinical
features in SCA1 and SCA2 are similar, although signs of
corticospinal involvement, pale discs and dysphagia are more
frequent in SCA1 and saccade-slowing and depressed tendon
reflexes are more frequent in SCA 2 (Burk et al., 1996; Schols
et al., 1997).
In the few cases of SCA1 and SCA2 which came to
neuropathological examination, a macroscopic pattern of
olivopontocerebellar atrophy (OPCA) with neuronal loss
and gliosis in the inferior olives, pons and cerebellum
was observed (Durr et al., 1995; Gilman et al., 1996;
Estrada et al., 1999). However microscopic examination
shows some differences between the two conditions
(Iwabuchi et al., 1999). In fact, the spinocerebellar and
vestibulocerebellar systems and the dentate nucleus
Table 2. D ( 10–3 mm2/s) of the brainstem, cerebellum and cerebral hemispheres in patients with SCA1 and
SCA2 and healthy subjects
SCA1 SCA2 Healthy controls
(n ¼ 9) (n ¼ 9) (n ¼ 20)
Region of interest
Pons 0.80 6 0.06 0.84 6 0.12* 0.74 6 0.11
MCP 1.28 6 0.11*** 1.08 6 0.22** 0.81 6 0.14
CWM 1.18 6 0.05*** 1.02 6 0.21 0.86 6 0.16
Medulla 0.97 6 0.09** 0.97 6 0.11** 0.77 6 0.16
Histograms
Brainstem and cerebellum
25th percentile 0.83 6 0.08** 0.90 6 0.07 *** 0.71 6 0.6
50th percentile 1.07 6 0.15** 1.19 6 0.11*** 0.86 6 0.10
Cerebral hemispheres
50th percentile 0.91 6 0.09 0.87 6 0.04 0.85 6 0.06
*P < 0.05 **P < 0.01 ***P < 0.001; all statistically significant P values refer to the difference between SCA1 or SCA2 patients and controls. No
statistically significant difference was observed between SCA1 and SCA2 for any of the MRI measurements. MCP ¼ middle cerebellar
peduncles; CWM ¼ cerebellar white matter.
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are affected in SCA1 and spared in SCA2, and the cere-
bellar cortex is more severely damaged in SCA2 than
in SCA1.
The features of OPCA on conventional MRI were defined
using either subjective evaluation of morphology and the
signal intensity of the brainstem and cerebellum (Savoiardo
et al., 1990; Ormerod et al., 1994) or morphometric measure-
ments (Wullner et al., 1993; Schols et al., 1997; Mascalchi
et al., 1998; Nagaoka et al., 1999). In particular, in hereditary
and sporadic OPCA Savoiardo and colleagues reported char-
acteristic thinning of the ventral pons and diffusely increased
signal intensity of the brainstem and cerebellar white matter in
proton density and T2-weighted images, with sparing of the
corticospinal tracts and the superior cerebellar peduncles
(Savoiardo et al., 1990). These last findings were reported
in advanced cases of SCA1 and SCA2 (Mascalchi et al., 1998;
Giuffrida et al., 1999).
The absolute volumes of the cerebellum and brainstem
in our normal subjects were in substantial agreement with
previous studies (Klockgether et al., 1998b; Raz et al.,
2001) The reductions in normalized volumes of the cerebel-
lum and brainstem we observed in SCA1 and SCA2 are in line
with the results of a previous study (Klockgether et al., 1998b)
which reported significantly more pronounced atrophy of the
cerebellum and brainstem in SCA2 than in SCA1.
The distribution pattern of increased D in the brainstem and
cerebellum that we observed in our SCA1 and SCA2 patients
matched the distribution of the neuropathological changes in
OPCA. In particular, D was increased throughout the brain-
stem and cerebellum and was more prominent in the middle
cerebellar peduncles, which are the site of the most severe
damage in OPCA (Lowe et al., 1997). The mild increase in D
in the pons might be related to inclusion in the region of
interest of the corticospinal tracts, which are characteristically
spared in OPCA. Although the exact pathological correlate of
increase in D in SCA1 and SCA2 cannot be established, it
probably reflects the wallerian degeneration of the white mat-
ter observed in OPCA (Lowe et al., 1997).
Diffusion tensor MRI enables evaluation of the fractional
anisotropy of the white matter, but was not employed in our
C
A B
Fig. 2 Histograms of brainstem and cerebellar D in one healthy control (A), one SCA1 patient (B) and one SCA2 (C) patient. Note the
different shape of the histogram and the rightward displacement of median (vertical line) values in B and C.
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study. However, an increase in mean diffusivity was highly
correlated with the decrease in diffusion anisotropy in a diffu-
sion tensor MRI study of the internal capsules in patients with
primary lateral sclerosis (Ulug et al., 2004). This is a neuro-
degenerative condition in which selective wallerian degenera-
tion of the corticospinal tracts is assumed to be due to
dysfunction and loss of the cortical motor neurons
(Lowe et al., 1997).
In degenerative diseases of the CNS, 1H-MRS shows a
decrease in the concentration of the putative neuronal and
axonal marker NAA or of the NAA/Cr ratio in the areas
where there is maximal neuronal damage and loss on neuro-
pathological examination (Gill et al., 1989). Preliminary MRS
studies in patients with SCAs included a small number of
patients (Davie et al., 1995; Mascalchi et al., 1998; Boesch
et al., 2001) and two of them were performed with a semi-
quantitative approach only (Mascalchi et al., 1998; Boesch
et al., 2001). The decrease in the concentration of NAA we
observed in the cerebellum of patients with SCA1 and SCA2
confirms the results of the above studies. Also, the pontine
reduction in NAA supports and extends the data obtained
with a semiquantitative approach in SCA1 (Mascalchi et al.,
1998). We observed lower concentrations of Cho and Cr in the
pons and of Cr in the cerebellum of SCA1 and SCA2 patients
compared with controls, but the differences were not statistic-
ally significant. A reduction in Cho has been reported in the
cerebellum of ADCA patients (Davie et al., 1995) and in
the Cho/Cr ratio in the pons of SCA1 patients (Mascalchi
et al., 1998). At variance with Boesch et al. (2001), who
observed a lactate peak in all of the four SCA2 patients they
examined, we observed a lactate peak in the pons of only
one SCA1 patient. Although the single-voxel technique is
the standard procedure for clinical quantitative 1H-MRS, it
has limited spatial resolution. In fact, with the voxel size
employed in this study, it is not possible to separate the dentate
nucleus from the surrounding white matter, which contains
either fibres connecting the cerebellar cortex to the nucleus
and the latter to the brainstem or afferent fibres from the brain-
stem to the cerebellar cortex. Hence, it is impossible from our
data to attribute a decrease in cerebellar NAA to dysfunction of
the dentate neurons or to wallerian degeneration of the adjacent
fibres due to damage in the cerebellar cortical or brainstem
neurons. Also, it is impossible to attribute a decrease in NAA in
the pons to damage of a particular grey structure or white matter
tract in the brainstem. This notwithstanding, taking into con-
sideration the distribution of the neuropathological changes
and the better quality of the pontine spectra compared with
those in the medulla (Mascalchi et al., 2002a), the basis pontis
can be chosen as the site of choice for the 1H-MRS evaluation of
neurodegeneration of the brainstem in OPCA.
Relaxation times of metabolites can affect the results of
quantitative and semiquantitative evaluation of spectra
(Kamada et al., 1994; Mascalchi et al., 2002b). The non-
significant changes in T2 relaxation times in the cerebellum
and pons of our SCA1 and SCA2 patients indicate that these
changes are not a general phenomenon and that, for the
purpose of metabolite quantification in these regions and in
these conditions, a single TE spectrum could suffice, enabling
a considerable shortening of the 1H-MRS acquisition times.
Overall, we did not observe significant differences between
SCA1 and SCA2 for any of the MR features. This is in line
with the substantial macroscopic similarity of the neuro-
degenerative process in SCA1 and SCA2 (Lowe et al., 1997;
Iwabuchi et al., 1999).
Table 3. Concentrations (mmol/l) and T2 relaxation times (ms) in the cerebellum and pons in patients with SCA1 or SCA2 and
healthy controls
SCA1 SCA2 Healthy
subjects
P
Cerebellum
Concentration 8.3 6 2.5 8.3 6 4.2 14.2 6 1.6 <0.01
NAA
T2 relaxation time 357 6 111 400 6 103 368 6 107 NS
Concentration 12.0 6 2.4 9.3 6 2.7 13.4 6 1.8 NS
Cr
T2 relaxation time 184 6 4.3 233 6 54 198 6 34 NS
Concentration 2.6 6 0.8 3.3 6 1.2 2.8 6 0.5 NS
Cho
T2 relaxation time 288 6 70 319 6 142 331 6 26 NS
Pons
Concentration 8.6 6 2.1 9.4 6 2.7 14.0 6 4.7 0.01
NAA
T2 relaxation time 323 6 81 365 6 64 351 6 46 NS
Concentration 6.2 6 1.8 5.8 6 1.4 7.7 6 3.4 NS
Cr
T2 relaxation time 165 6 39 284 6 138 189 6 33 NS
Concentration 2.4 6 0.8 3.2 6 0.9 3.4 6 0.8 NS
Cho
T2 relaxation time 352 6 68 251 6 46 305 6 49 NS
NS ¼ not significant.
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The second purpose of our study was to explore the rela-
tionship between MR and clinical findings in patients with
SCA1 and SCA2. The severity of the neurological signs was
assessed with a dedicated scale (Filla et al., 1990) which
includes evaluation of corticospinal changes that are com-
monly observed in patients with SCA1 and SCA2.
In our sample we found a correlation between the severity
of the neurological signs and the disease duration in SCA1 but
not in SCA2. However, Filla et al. (1999) found a correlation
between the severity of brainstem and cerebellar signs and
disease duration in 30 families with SCA2.
In three previous studies, MRI-based morphometry mea-
surements (Burk et al., 1996; Nagaoka et al., 1999) or sub-
jective evaluations of brainstem and cerebellar atrophy
(Giuffrida et al., 1999) were analysed with respect to disease
duration, and no correlation was found in either SCA1 or
SCA2. In these studies the correlation with the severity
of neurological deficits was not assessed. In a recent study
using a different approach with voxel-based morphometry,
an inverse correlation was found between the cerebellar
grey matter volume of both hemispheres and the severity
of cerebellar signs in nine patients with SCA2 (Brenneis
et al., 2003).
In a prior study we found a correlation between the median
of the D in the brainstem and cerebellum in SCA1 and SCA2,
considered altogether, and the IACRS score (Della Nave et al.,
2004).
In prior 1H-MRS studies of patients with SCA1 or SCA2,
detailed quantitative scales of the neurological deficit were
not used to address the clinical correlation.
We found a correlation between the loss of bulk, increased D
and decreased NAA concentration in the brainstem on the one
hand and the severity of the neurological deficit on the other
hand in SCA1 but not in SCA2. In our opinion, three hypothe-
tical explanations for this discrepancy can be proposed.
First, thedifferentcorrelationbetweenbrainstemMRfindings
and IACRS scores in SCA1 and SCA2 could reflect the
microscopic neuropathological data (Iwabuchi et al., 1999)
showing that the damage of the brainstem grey nuclei and
white matter tracts is predominant in SCA1 compared with
SCA2.
Secondly, the lack of correlation in our SCA2 patients
could be due to the relatively narrow range of severity of
the neurological deficit (IACRS score from 12 to 19) in
these patients compared with that observed in our SCA1
patients (IACRS score from 3 to 24). However, this hypothesis,
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Fig. 3 Data illustrating the relationship between the IACRS score and the volumes of the brainstem normalized to the PCF (A), the median
of the brainstem and cerebellar D (B) and the concentration of NAA in the pons (C) and in SCA1 patients (open squares) and SCA2 patients
(filled circles). A significant (P < 0.05) correlation between clinical severity and the three MR parameters is observed for SCA1 (thick lines)
(r ¼ 0.74 in A; r ¼ 0.70 in B; r ¼ 0.63 in C) but not for SCA 2 (thin lines).
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which deserves to be addressed in further studies with greater
sample size, is at variance with the observation that, in our
study, SCA1 patients had shorter and SCA2 patients longer
disease duration. This would suggest a different temporal pro-
gression of neurodegeneration in SCA1 and SCA2, which is in
line with the observation that the clinical deficit has a later onset
and faster progression in SCA1 and an earlier onset and slower
progression in SCA2 (Klockgether et al., 1998a). Moreover,
MRI (Schols et al., 1997) and the pathological examination
(Estrada et al., 1999) demonstrate earlier and more pronounced
brainstem and cerebellar atrophy in SCA2 than in SCA1. These
elements support the third hypothesis—that the discrepancy
might reflect a different progression of neurodegeneration in
SCA1 and SCA2, with an earlier onset and slower progression,
consistent with a relatively indolent process, in SCA2 and later
onset and faster progression, consistent with a relatively
aggressive process, in SCA1. We speculate that functional
compensation based on neuronal plasticity might be more
efficient in limiting the clinical impact of the neurodege-
neration in SCA2. Functional MRI might provide relevant
insights into the pathophysiology of degenerative ataxias
and is currently under evaluation in our institute.
In our series, the volume of the cerebellum and the concen-
tration of NAA in the dentate and peridentate region were
reduced in patients with SCA1 and SCA2, but no correlation
with theseverityof the neurologicaldeficit wasobserved. How-
ever, there was a correlation between the loss of volume of the
cerebellum (and also the increase in brainstem and cerebellar
mean diffusivity in SCA1) and disease duration in SCA1 and
SCA2. The lack of correlation between NAA concentration in
thedentateandperidentate regionandclinicaldeficit inSCA2is
not unexpected taking into account the location of our cerebellar
voxel and the sparing of the dentate found on neuropatholo-
gical examination in SCA2. More difficult to explain is the
lack of correlation between the cerebellar volume and the
clinical deficit in SCA1 and SCA2, and between the cerebellar
NAA concentration and the clinical deficit in SCA1. These
negative results might arise from the choice we made in terms
of volumetric MRI measurements and the location of the
single voxel for 1H-MRS. Other MR features which were
not assessed in our study, such as the volume of the vermis
(Klockgether et al., 1998a) and the NAA concentration of the
cerebellar cortex (Mascalchi et al., 2002a) might correlate
better with the clinical deficit and deserve further inves-
tigation. Moreover quantitative proton MR spectroscopic
imaging, which enables a panoramic evaluation of the brain-
stem and cerebellum with smaller voxel size compared with
the single-voxel technique, (Jacobs et al., 2001) could be
especially suited for this purpose.
In triplet neurodegenerative diseases as SCA1 and SCA2,
the number of triplet expansions is significantly correlated
with age at onset and the rate of progression of the disease
(Giunti et al., 1998; Filla et al., 1999; Martin, 1999). We did
not evaluate the correlation of MR findings with triplet
numbers. However, in two prior studies no correlation
between the number of triplets and the severity of brainstem
and cerebellar atrophy was found (Klockgether 1998b;
Giuffrida et al., 1999).
The correlation between degeneration of the brainstem, as
detected by volumetric and diffusion MRI and quantitative
1H-MRS, and the severity of neurological deficit in our SCA1
patients indicates that MR could assess disease progression in
longitudinal studies of this condition. Moreover, our results
support the view that MR might be employed as an outcome
measure beside quantitative clinical and paraclinical tests
(Velazquez Perez et al., 2001; Yabe et al., 2001; Schulte
et al., 2002; Sakai and Miyoshi 2002) in future therapeutic
trials in SCA1 driven by advances in the molecular pathology
of this condition (Martin, 1999; Humbert and Saudou, 2002;
Okazawa et al., 2002). For this purpose, diffusion MRI and
1H-MRS might be more sensitive markers (Kalra et al., 1998)
than volumetric MRI since they can give information about
the condition of the surviving tissue compared with a measure
(brain volume) of the irreversible tissue loss. Obviously, this
requires preliminary estimation of the evolution of the volu-
metric, diffusion and spectroscopy changes in longitudinal
studies of untreated patients, which are not available yet,
and standardization of the MR techniques in the case of a
multicentre trial.
In conclusion, our study indicates that both SCA1 and SCA2
are characterized by loss of bulk, increased mean diffusivity
and a decrease in the concentration of NAA in the brainstem
and cerebellum. The changes in the brainstem correlate
with the neurological deficit in SCA1 and could be
employed as measures of the severity and progression of
this condition.
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